Considerations For Developing A Dosimetry-Based Cumulative Risk Assessment Approach For Mixtures of Environmental Contaminants (Final Report)
Overview
Citation
Background
The purpose of this final report is to serve as a learning tool for EPA scientists and risk assessors in choosing to embark on PBPK modeling for cumulative risk assessment. It is structured around the 10-step procedure developed by the Office of Pesticide programs for conducting a cumulative risk assessment and the foundations of mixtures and cumulative risk assessment as conducted by the U.S. EPA. The approach is conducted in two phases, with the initial phase devoted to deciphering chemical-specific information to group chemicals, and the second phase devoted to guiding the application of PBPK modeling and the interpretation of dosimetry results to better inform the likelihood of chemical interactions and provide insight as to the likelihood of those interactions at environmentally-relevant exposure levels.
This is the final report. Portions of this report may also be found published in the peer-reviewed literature.
History/Chronology
Date | Description |
---|---|
2003 | EPA award releases a solicitation for a contract to develop a report for the Method of Analysis to Perform a Tissue-Based Cumulative Risk Assessment for Mixtures of Chemicals. |
2004 | A draft document is circulated for internal review. |
2005 | A draft document is subjected to an external panel review. |
Sep 2007 | EPA finalized the report. |
Apr 2009 | EPA released the final report. |
Download(s)
This document has been reviewed in accordance with U.S. Environmental Protection Agency policy and approved for publication. Mention of trade names or commercial products does not constitute endorsement or recommendation for use.
- U.S. EPA/Considerations for Developing a Dosimetry-Based Cumulative Risk Assessment Approach for Mixtures of Environmental Contaminants (Final Report) (PDF) (77 pp, 595.7 KB, about PDF)
- Appendix A: PHYSIOLOGICALLY-BASED PHARMACOKINETIC/PHARMACODYNAMIC (PBPK/PD) MODELING REFERENCE (PDF) (16 pp, 515.6 KB, about PDF)
- Appendix B: HOW TO INCORPORATE CREDIBLE HUMAN ENZYME STUDIES INTO THE PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODELING AND RISK ASSESSMENT PROCESS Reference (PDF) (19 pp, 1.2 MB, about PDF)
- Appendix C: INFORMATION ON CHEMICAL MIXTURES AND THEIR COMPONENT CHEMICALS (PDF) (86 pp, 994.1 KB, about PDF)
- Appendix D: Method of Analysis to Perform a Tissue-Based Cumulative Risk Assessment for Mixtures of Chemicals (PDF) (22 pp, 252.9 KB, about PDF)
If you have a disability and the format of any material on our web pages interferes with your ability to access the information, please reach out to us using the Contact Us about IRIS form for assistance. To enable us to respond in a manner most helpful to you, please indicate the nature of the accessibility problem, the web address of the requested material, your preferred format in which you want to receive the material (electronic format (ASCII, etc.), standard print, large print, etc.), and your contact information.
Document Related Link(s)
- EPA Guidance on Cumulative Risk Assessment of Pesticide Chemicals that Have a Common Mechanism of Toxicity
- WHO. 2010. Characterization and Application of PBPK Models in Risk Assessment (Final Report)
- Supplementary Guidance for Conducting Health Risk Assessment of Chemical Mixtures
- Guidelines for the Health Risk Assessment of Chemical Mixtures (Final Report, 1986)
- Health Risk Assessment of Chemical Mixtures
- Approaches For the Application of Physiologically Based Pharmacokinetic (PBPK) Models and Supporting Data In Risk Assessment (Final Report)